Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
39.95
+0.54 (1.37%)
At close: Oct 26, 2026, 4:00 PM EDT
39.50
-0.45 (-1.13%)
After-hours: Oct 26, 2026, 7:46 PM EDT
Teva Pharmaceutical Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $47 | Buy | Maintains | $47 | +17.65% | Oct 16, 2026 |
| Scotiabank | Scotiabank | Buy Maintains $47 | Buy | Maintains | $47 | +17.65% | Oct 13, 2026 |
| Leader Capital Markets | Leader Capital Markets | Buy Maintains $50 | Buy | Maintains | $50 | +24.41% | Oct 13, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $50 | Buy | Maintains | $50 | +25.16% | Oct 12, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $40 → $50 | Buy | Maintains | $40 → $50 | +25.16% | Oct 11, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $43 | Buy | Reiterates | $43 | +7.63% | Oct 9, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $44 | Buy | Reiterates | $44 | +10.14% | Oct 1, 2026 |
| TD Cowen | TD Cowen | Buy Initiates $55 | Buy | Initiates | $55 | +37.67% | Oct 1, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.